InsidersTradesSigma
Track the 영진약품 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 영진약품 has published 6 reports. Market capitalisation: €223.5bn. The latest transaction was reported on 5 March 2026 (Other). Among the most active insiders: 영진약품. Every trade is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.